Zaki Sellam
I am happy to introduce you Zaki Sellam, a seasoned Biotech Executive with over two decades of leadership in both cancer & immunology drug development. Zaki has a proven track record, from implementing discovery-stage drug programs through to translational and clinical development, all while building strategic alliances in the pharmaceutical and academic arena.
As a serial entrepreneur, Zaki has founded from scratch numerous start-ups in oncology and immunology, securing close to millions in equity financing over the last 15 years. Notably, he is the co-founder and CEO of Landmark BioVentures AG, a Biotech Building platform in Basel, with a portfolio of 7 promising biotech start-ups. Landmark BioVentures is now subject to the integration within a NASDAQ listed SPAC.
Beyond his entrepreneurial ventures, Zaki has always kept advisory activities, providing both corporate and R&D strategic insights to start-ups, Accelerators, Incubators and Pharma organizations.